John Kuriyan

John is a professor of biochemistry and molecular biology in the Department of Molecular and Cell Biology at the University of California, Berkeley. He is a Howard Hughes Investigator, a member of the National Academy of Sciences, and was elected a Foreign Member of the Royal Society, London (2015). John’s research focuses on the structure and mechanism of the enzymes and molecular switches that carry out cellular signal transduction.

John is the recipient of many awards, including the 2005 Richard Lounsbery Award, US National Academy of Science and the 2009 Merck Award, American Society of Biochemistry and Molecular Biology for his contributions to structural biology. He is an academic founder of Nurix Pharmaceuticals and a member of the advisory board of Carmot Therapeutics and Amgen, Inc.

John received his B.S. from Juniata College and his Ph.D. from the Massachusetts Institute of Technology.